Back

Application of win ratio methodology in the Global SYMPLICITY Registry for patients with atrial fibrillation or obstructive sleep apnea

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Hypertension e-posters Device Treatment and Intervention ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Felix Mahfoud

University Hospital Basel, Basel (Switzerland)

110 More presentations in this session

Presentation thumbnail
Exercise intensities modulate cognitive function in spontaneously hypertensive rats through oxidative mediated synaptic plasticity in hippocampus
Professor T. Lee (Tainan, TW)
Abstract Slides
Presentation thumbnail
Arterial stiffness and the risk of heart failure formation in rotational shift workers in the arctic
Doctor N. Shurkevich (Tyumen, RU)
Abstract Slides
Presentation thumbnail
Marital status, cardiovascular events, and intensive blood pressure lowering among men and women in the Systolic Blood Pressure Intervention Trial
Doctor M. Pareek (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Greater event rates in high-risk patients with a history of heart disease: from the Systolic Blood Pressure Intervention Trial (SPRINT)
Doctor M. Pareek (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Renal denervation in truly resistant hypertensive patients: six-year follow-up results of a single-center study
Doctor M. Ionov (Saint Petersburg, RU)
Abstract Slides

Access the full session

Session thumbnail
Hypertension e-posters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Systematic virtual sleep apnoea management in patients with atrial fibrillation undergoing catheter ablation: outcomes on atrial fibrillation symptom severity
12 April 2026
thumbnail
Webinar
The HFA Journal Club: win ratio in heart failure trials: for the win?
24 March 2025
thumbnail
Congress Presentation
Long-term outcomes after renal denervation in the two defined ESC guideline-recommended patient groups: an analysis from the Global SYMPLICITY Registry DEFINE
31 August 2025
thumbnail
Congress Presentation
Impact of systolic blood pressure on ischemic and bleeding events and the efficacy and safety of rivaroxaban monotherapy: a post-hoc analysis of the AFIRE trial
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources